在心力衰竭患者中左束支部区域节奏的结果:系统性审查
Hina Ahmed Siddiqui1, Mounika Kotte1, Hilana Soliman Omar1
1Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan.
概括
左捆支部区域节奏 (LBBAP) 改善心脏功能和心力衰竭患者的电同步. 与传统方法相比,这种生理节奏显示出较低的住院率和有利的安全概况.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 医疗器械 医疗器械
背景情况:
- 左捆分支区域节奏 (LBBAP) 是一种新兴的生理节奏技术.
- 它旨在通过引入左导系统来恢复心室电同步.
- LBBAP被认为是传统节拍的替代品,特别是对于心力衰竭患者,心脏左心室排气分数减少 (LVEF ≤50%).
研究的目的:
- 系统地审查和综合关于左捆分支区域节奏 (LBBAP) 的现有文献.
- 与传统节奏策略相比,评估LBBAP的疗效和安全性.
- 评估LBBAP对心脏功能,电同步和临床结果的影响.
主要方法:
- 在PubMed,MEDLINE和Scopus进行了系统的文献搜索,直到2024年12月.
- 包括5680名患者在内的16项研究被纳入了分析.
- 评估的结果包括LVEF,QRS持续时间,住院率,并发症和死亡率的变化,由于研究异质性,使用了定性叙事综合.
主要成果:
- LBBAP在心脏功能上显著改善,增加了LVEF和减少了QRS持续时间,表明电同步增强.
- 与LBBAP相关的并发症率很低,罕见的肺胸部和脱事件发生.
- 与心力衰竭相关的住院治疗较低 LBBAP (19.05%) 与双心室节拍 (30.00%) 相比,在节拍策略中死亡率始终较低.
结论:
- 左捆支部区域节奏 (LBBAP) 是改善电同步和心脏功能的一种有前途的策略.
- 它表现出有利的短期到中期安全概况.
- 需要进一步的大规模随机对照试验来确认长期的疗效和安全性.
相关概念视频
01:29Heart Failure II: Pathophysiology
929
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
01:17Pathophysiology of Heart Failure
3.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
01:27Heart Failure I: Introduction
886
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
01:22Heart Failure VI: Adjunct Therapies
340
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
01:22Heart Failure Drugs: Diuretics
971
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971
01:30Heart Failure V: Medical Management
319
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319